Documentation & workflow
Nabla
Generates structured clinical notes from patient-clinician conversations for review and use in care workflows.
Designed for
Clinician
Care setting
Ambulatory care
Specialty
Multispecialty
Our assessment
Nabla has meaningful comparative evidence for reducing documentation burden, including randomized health-system evaluation. That creates more confidence in efficiency claims than in claims about note fidelity, multilingual performance, or safety after later model changes.
Based on public sources. RIR did not independently test this product. This is not an endorsement or recommendation.
What the evidence supports
Reviewed official materials establish a marketed ambient clinical documentation assistant.
What remains uncertain
Independent performance across languages, specialties, and changing model versions remains limited in the represented sources.
How it was studied
Nabla was one of two products tested in a pragmatic randomized trial of 238 outpatient physicians across 14 specialties. The primary outcome was change in EHR note-writing time, with clinician burden and experience also assessed.
Product facts
Sources reviewed
3 public sources represented in this evidence profile.
Evidence source base
Published comparative health-system evidence plus developer documentation. The exact deployed version and later model changes need to be matched to the study.
Important limitation
The trial is meaningful implementation evidence but does not fully characterize severe note errors, multilingual performance, downstream record effects, or performance after product updates.
Questions to ask